Have we finally found a treatment with Covid-19? The answer is "yes" for an American laboratory which presents Remdesivir as the cure for the disease. The drug, developed as part of the Ebola epidemic, is said to speed healing. Donald Trump wants to distribute it as soon as possible. For doctor Jimmy Mohamed, doctor and columnist on Europe 1, Remdesivir constitutes "a hope" and "a track", but is not the miracle cure.
>> LIVE - Coronavirus: follow the evolution of the situation Thursday April 30
The findings of a Chinese study conducted earlier suggest that the drug does not reduce mortality. "[It] decreases the intensity of the symptoms and the number of days you are sick, on the other hand on mortality it has no impact," says Jimmy Mohamed. These conclusions are also confirmed by the scientific journal The Lancet .
>> Find all of Nathalie Levy's programs in replay and podcast here
No consideration of mortality
In addition, Doctor Jimmy Mohamed points out some pitfalls in the work of the American laboratory. "When we do a study, we need a 'major criterion' that we will validate," he said, adding that mortality was one of them. However, this fundamental fact was made obsolete along the way, for no apparent reason. The researchers only focused on the number of sick days.
CORONAVIRUS ESSENTIALS
> How many deaths at home should be added to the epidemic?
> What is the purpose of AlloCOVID, the telephone platform that uses artificial intelligence?
> Why we will have to wait before finding masks in pharmacies
> Coronavirus: can the MMR vaccine be dangerous for children?
> These platforms which help to find a job during confinement
"The study is not powerful enough," concludes Jimmy Mohamed, who recommends continuing clinical trials. "Currently, this is a lead, but it will not allow us to treat all cases of coronavirus."